153 related articles for article (PubMed ID: 20139290)
1. Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesis.
Singh RP; Mathews ME; Kaufman M; Riga A
Br J Ophthalmol; 2010 Feb; 94(2):170-3. PubMed ID: 20139290
[TBL] [Abstract][Full Text] [Related]
2. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
3. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
6. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.
Kivilcim M; Peyman GA; El-Dessouky ES; Kazi AA; Cheema R; Hegazy H
Ophthalmic Surg Lasers; 2000; 31(6):474-8. PubMed ID: 11095124
[TBL] [Abstract][Full Text] [Related]
7. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoretic delivery of triamcinolone acetonide: a preliminary study in hairless rats.
Shigeki S; Murakami T; Kiyonaka G; Yata N; Ikuta Y
Scand J Plast Reconstr Surg Hand Surg; 1996 Sep; 30(3):177-81. PubMed ID: 8885011
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
Felt-Baeyens O; Eperon S; Mora P; Limal D; Sagodira S; Breton P; Simonazzi B; Bossy-Nobs L; Guex-Crosier Y; Gurny R
Int J Pharm; 2006 Sep; 322(1-2):6-12. PubMed ID: 16824708
[TBL] [Abstract][Full Text] [Related]
10. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
Kamppeter BA; Cej A; Jonas JB
Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
[TBL] [Abstract][Full Text] [Related]
11. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye.
Santer V; Chen Y; Kalia YN
Eur J Pharm Biopharm; 2018 Nov; 132():157-167. PubMed ID: 30266666
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide.
Berridge MS; Heald DL; Muswick GJ; Leisure GP; Voelker KW; Miraldi F
J Nucl Med; 1998 Nov; 39(11):1972-7. PubMed ID: 9829591
[TBL] [Abstract][Full Text] [Related]
13. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.
Olsen TW; Feng X; Wabner K; Conston SR; Sierra DH; Folden DV; Smith ME; Cameron JD
Am J Ophthalmol; 2006 Nov; 142(5):777-87. PubMed ID: 16989764
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
McGee DH; Dembinska O; Gruebbel MM
Int J Toxicol; 2005; 24(6):419-25. PubMed ID: 16393934
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection.
Nan K; Sun S; Li Y; Qu J; Li G; Luo L; Chen H; Cheng L
Br J Ophthalmol; 2010 May; 94(5):654-8. PubMed ID: 20447969
[TBL] [Abstract][Full Text] [Related]
16. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
17. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
Blatsios G; Tzimas AS; Mattheolabakis G; Panagi Z; Avgoustakis K; Gartaganis SP
Curr Eye Res; 2010 Oct; 35(10):916-24. PubMed ID: 20858113
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
Korodi T; Lachmann B; Kopelent-Frank H
Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
[TBL] [Abstract][Full Text] [Related]
20. Short-term effect of intracameral triamcinolone acetonide on corneal endothelium using the rabbit model.
Oh JY; Wee WR; Lee JH; Kim MK
Eye (Lond); 2007 Jun; 21(6):812-8. PubMed ID: 16751761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
